<SEC-DOCUMENT>0001213900-21-021520-index.html : 20210414
<SEC-HEADER>0001213900-21-021520.hdr.sgml : 20210414
<ACCEPTANCE-DATETIME>20210414160303
ACCESSION NUMBER:		0001213900-21-021520
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20210412
FILED AS OF DATE:		20210414
DATE AS OF CHANGE:		20210414

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Barone Samuel B.
		CENTRAL INDEX KEY:			0001614995

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39438
		FILM NUMBER:		21825726

	MAIL ADDRESS:	
		STREET 1:		C/O AVALANCHE BIOTECHNOLOGIES, INC.
		STREET 2:		1035 O'BRIEN DRIVE, SUITE A
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025

	FORMER NAME:	
		FORMER CONFORMED NAME:	Barone Sameul B.
		DATE OF NAME CHANGE:	20140728

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Gemini Therapeutics, Inc. /DE
		CENTRAL INDEX KEY:			0001816736
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				851613057
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		300 ONE KENDALL SQUARE, 3RD FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		(617) 401-4400

	MAIL ADDRESS:	
		STREET 1:		300 ONE KENDALL SQUARE, 3RD FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FS Development Corp.
		DATE OF NAME CHANGE:	20200702
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<TEXT>
Document 1 - file: ownership.html

Document 1 - RAW XML: ownership.xml

</DOCUMENT>
</SEC-DOCUMENT>